KRONOS BIO INC (KRON) Stock Earnings & Estimates
NASDAQ:KRON - US50107A1043 - Common Stock
0.88 USD
+0.01 (+1.49%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.288M | 9.848M 56.62% | -100.00% | 15.3M | 45.9M 200.00% | 71.4M 55.56% | 96.9M 35.71% | 122.4M 26.32% | |||
| EBITDA YoY % growth | -134.85M 9.75% | -115.065M 14.67% | -61.716M 46.36% | -92.79M -50.35% | -178.225M -92.07% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -137.12M 9.43% | -117.201M 14.53% | -63.432M 45.88% | -81.6M -28.64% | -86.7M -6.25% | -68.34M 21.18% | -62.22M 8.96% | -60.18M 3.28% | -57.12M 5.08% | -55.08M 3.57% | |
| Operating Margin | N/A | -1,863.88% | -644.11% | N/A | N/A | -446.67% | -135.56% | -84.29% | -58.95% | -45.00% | |
| EPS YoY % growth | -2.37 13.82% | -1.86 21.52% | N/A 28.71% | -1.33 | -1.38 -3.85% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.21 20.67% | -0.21 6.87% | -0.27 -1.56% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.149M 7.43% | -14.28M 9.14% | -15.81M -42.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 13.83% | -0.25 | % | |
| Q4 2024 Q2Q % growth | 23.20% | -0.26 | % | |
| Q3 2024 Q2Q % growth | -0.23 57.41% | -0.28 | 0.05 | 18.74% |
| Q2 2024 Q2Q % growth | -0.27 48.08% | -0.34 | 0.07 | 21.57% |
| Q1 2024 Q2Q % growth | -0.29 36.96% | -0.43 | 0.14 | 32.71% |
| Q4 2023 Q2Q % growth | -0.34 39.29% | -0.54 | 0.20 | 36.51% |
| Q3 2023 Q2Q % growth | -0.54 5.26% | -0.52 | -0.02 | -3.30% |
| Q2 2023 Q2Q % growth | -0.52 11.86% | -0.47 | -0.05 | -10.83% |
| Q1 2023 Q2Q % growth | -0.46 29.23% | -0.45 | -0.01 | -1.34% |
| Q4 2022 Q2Q % growth | -0.56 50.44% | -0.60 | 0.04 | 6.31% |
| Q3 2022 Q2Q % growth | -0.57 6.56% | -0.67 | 0.10 | 14.29% |
| Q2 2022 Q2Q % growth | -0.59 -11.32% | -0.71 | 0.12 | 16.41% |
| Q1 2022 Q2Q % growth | -0.65 -35.42% | -0.67 | 0.02 | 3.15% |
| Q4 2021 Q2Q % growth | -1.13 -61.43% | -1.12 | -0.01 | -0.90% |
| Q3 2021 Q2Q % growth | -0.61 84.75% | -1.03 | 0.42 | 40.91% |
| Q2 2021 Q2Q % growth | -0.53 | -0.63 | 0.10 | 16.46% |
| Q1 2021 Q2Q % growth | -0.48 | -0.44 | -0.04 | -8.56% |
| Q4 2020 Q2Q % growth | -0.70 | -0.80 | 0.10 | 12.83% |
| Q3 2020 Q2Q % growth | -4.00 | -1.50 | -2.50 | -166.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.864M -26.03% | 1.275M | 589K | 46.20% |
| Q4 2024 Q2Q % growth | 2.27M -0.70% | 2.509M | -239K | -9.53% |
| Q3 2024 Q2Q % growth | 2.37M 158.45% | 2.142M | 228K | 10.64% |
| Q2 2024 Q2Q % growth | 2.688M 44.21% | 1.556M | 1.132M | 72.75% |
| Q1 2024 Q2Q % growth | 2.52M 106.39% | 1.02M | 1.5M | 147.06% |
| Q4 2023 Q2Q % growth | 2.286M | 1.556M | 730K | 46.92% |
| Q3 2023 Q2Q % growth | 917K | 1.428M | -511K | -35.78% |
| Q2 2023 Q2Q % growth | 1.864M | 1.7M | 164K | 9.65% |
| Q1 2023 Q2Q % growth | 1.221M | 5.738M | -4.517M | -78.72% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |